Hypertension, Vol 13, 3-8, Copyright © 1989 by American Heart Association
TD Berry, SJ Hasstedt, SC Hunt, LL Wu, JB Smith, KO Ash, H Kuida and RR Williams
The inheritance of 12-hour overnight total urinary kallikrein excretion and
its association with family history of essential hypertension were studied
in 405 normotensive adults and 391 youths in 57 Utah pedigrees. Total
urinary kallikrein excretion was highly familial with 51% of the total
variance attributable to a dominant allele for high total urinary
kallikrein excretion and 27% attributable to the combined effects of
polygenes and shared family environment. An estimated 28% of the population
has one or two copies of the dominant allele for high total urinary
kallikrein excretion (2.3 SD units higher than the low homozygotes). About
83% of the population could be assigned to one of the two genotypic
populations. Individuals with the high total urinary kallikrein excretion
genotype were significantly less likely to have one or two hypertensive
parents (relative odds = 0.56, p = 0.042). We conclude that a dominant
allele expressed as high total urinary kallikrein excretion may be
associated with decreased risk of essential hypertension. Further studies
should be performed to confirm this finding and to test for interactions
between this apparently protective gene and other genetic and environmental
determinants of essential hypertension.
ARTICLES
A gene for high urinary kallikrein may protect against hypertension in Utah kindreds
Department of Medicine, University of Utah Medical School, Salt Lake City.
This article has been cited by other articles:
 |
|
 |
|
  N. Picard, D. Eladari, S. El Moghrabi, C. Planes, S. Bourgeois, P. Houillier, Q. Wang, M. Burnier, G. Deschenes, M. A. Knepper, et al. Defective ENaC Processing and Function in Tissue Kallikrein-deficient Mice J. Biol. Chem., February 22, 2008; 283(8): 4602 - 4611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chao and L. Chao Kallikrein-kinin in stroke, cardiovascular and renal disease Exp Physiol, May 1, 2005; 90(3): 291 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Meneton, J. Loffing, and D. G. Warnock Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule Am J Physiol Renal Physiol, October 1, 2004; 287(4): F593 - F601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Slim, F. Torremocha, T. Moreau, A. Pizard, S. C. Hunt, A. Vuagnat, G. H. Williams, F. Gauthier, X. Jeunemaitre, and F. Alhenc-Gelas Loss-of-Function Polymorphism of the Human Kallikrein Gene with Reduced Urinary Kallikrein Activity J. Am. Soc. Nephrol., April 1, 2002; 13(4): 968 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dendorfer, S. Wolfrum, M. Wagemann, F. Qadri, and P. Dominiak Pathways of bradykinin degradation in blood and plasma of normotensive and hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2182 - H2188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Meneton, M. Bloch-Faure, A. A. Hagege, H. Ruetten, W. Huang, S. Bergaya, D. Ceiler, D. Gehring, I. Martins, G. Salmon, et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice PNAS, February 15, 2001; (2001) 51619598. [Abstract] [Full Text]
|
|
|
|
|
|
D. Wang, H. Yoshida, Q. Song, L. Chao, and J. Chao Enhanced renal function in bradykinin B2 receptor transgenic mice Am J Physiol Renal Physiol, March 1, 2000; 278(3): F484 - F491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Emanueli, R. Maestri, D. Corradi, R. Marchione, A. Minasi, M. G. Tozzi, M. B. Salis, S. Straino, M. C. Capogrossi, G. Olivetti, et al. Dilated and Failing Cardiomyopathy in Bradykinin B2 Receptor Knockout Mice Circulation, December 7, 1999; 100(23): 2359 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jin, L. Chao, and J. Chao Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR Am J Physiol Renal Physiol, March 1, 1999; 276(3): F476 - F484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kainulainen, M. Perola, J. Terwilliger, J. Kaprio, M. Koskenvuo, A.-C. Syvanen, E. Vartiainen, L. Peltonen, and K. Kontula Evidence for Involvement of the Type 1 Angiotensin II Receptor Locus in Essential Hypertension Hypertension, March 1, 1999; 33(3): 844 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Marceau, J. F. Hess, and D. R. Bachvarov The B1 Receptors for Kinins Pharmacol. Rev., September 1, 1998; 50(3): 357 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Madeddu, A. F. Milia, M. B. Salis, L. Gaspa, W. Gross, A. Lippoldt, and C. Emanueli Renovascular Hypertension in Bradykinin B2-Receptor Knockout Mice Hypertension, September 1, 1998; 32(3): 503 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Emanueli, E. Fink, A. F. Milia, M. B. Salis, M. Conti, M. P. Demontis, and P. Madeddu Enhanced Blood Pressure Sensitivity to Deoxycorticosterone in Mice With Disruption of Bradykinin B2 Receptor Gene Hypertension, June 1, 1998; 31(6): 1278 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yayama, C. Wang, L. Chao, and J. Chao Kallikrein Gene Delivery Attenuates Hypertension and Cardiac Hypertrophy and Enhances Renal Function in Goldblatt Hypertensive Rats Hypertension, May 1, 1998; 31(5): 1104 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yu, D. W. Bowden, B. J. Spray, S. S. Rich, and B. I. Freedman Identification of Human Plasma Kallikrein Gene Polymorphisms and Evaluation of Their Role in End-Stage Renal Disease Hypertension, April 1, 1998; 31(4): 906 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Madeddu, M. V. Varoni, D. Palomba, C. Emanueli, M. P. Demontis, N. Glorioso, P. Dessi-Fulgheri, R. Sarzani, and V. Anania Cardiovascular Phenotype of a Mouse Strain With Disruption of Bradykinin B2-Receptor Gene Circulation, November 18, 1997; 96(10): 3570 - 3578. [Abstract] [Full Text]
|
|
|
|
|
|
C. Wang, P. Ford, C. Chao, L. Chao, and J. Chao Effect of cyclosporin A on the expression of tissue kallikrein, kininogen, and bradykinin receptor in rat Am J Physiol Renal Physiol, November 1, 1997; 273(5): F783 - F789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Alfie, D. H. Sigmon, S. I. Pomposiello, and O. A. Carretero Effect of High Salt Intake in Mutant Mice Lacking Bradykinin-B2 Receptors Hypertension, January 1, 1997; 29(1): 483 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-M. Chen, J.-x. Ma, Y.-M. Liang, L. Chao, and J. Chao Tissue Kallikrein-binding Protein Reduces Blood Pressure in Transgenic Mice J. Biol. Chem., November 1, 1996; 271(44): 27590 - 27594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chao and L. Chao Functional Analysis of Human Tissue Kallikrein in Transgenic Mouse Models Hypertension, March 1, 1996; 27(3): 491 - 494. [Abstract] [Full Text]
|
|
|
|
|
|
H. S. Margolius Kallikreins and Kinins : Some Unanswered Questions About System Characteristics and Roles in Human Disease Hypertension, August 1, 1995; 26(2): 221 - 229. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Takiyyuddin, R. J. Parmer, M. T. Kailasam, J. H. Cervenka, B. Kennedy, M. G. Ziegler, M.-C. Lin, J. Li, C. E. Grim, F. A. Wright, et al. Chromogranin A in Human Hypertension : Influence of Heredity Hypertension, July 1, 1995; 26(1): 213 - 220. [Abstract] [Full Text]
|
|
|
|
|
|
W. Xiong, J. Chao, and L. Chao Muscle Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats Hypertension, April 1, 1995; 25(4): 715 - 719. [Abstract] [Full Text]
|
|
|
|
|
|
J.-x. Ma, Z. Yang, J. Chao, and L. Chao Intramuscular Delivery of Rat Kallikrein-binding Protein Gene Reverses Hypotension in Transgenic Mice Expressing Human Tissue Kallikrein J. Biol. Chem., January 6, 1995; 270(1): 451 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Meneton, M. Bloch-Faure, A. A. Hagege, H. Ruetten, W. Huang, S. Bergaya, D. Ceiler, D. Gehring, I. Martins, G. Salmon, et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice PNAS, February 27, 2001; 98(5): 2634 - 2639. [Abstract] [Full Text] [PDF]
|
|